|
1
|
Chen CH and Chen RJ: Prevalence of
telomerase activity in human cancer. J Formos Med Assoc.
110:275–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shtessel L and Ahmed S: Telomere
dysfunction in human bone marrow failure syndromes. Nucleus.
2:24–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harley CB, Futcher AB and Greider CW:
Telomeres shorten during ageing of human fibroblasts. Nature.
345:458–460. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oeseburg H, de Boer RA, van Gilst WH and
van der Harst P: Telomere biology in healthy aging and disease.
Pflugers Arch. 459:259–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watson JM and Riha K: Telomeres, aging,
and plants: From weeds to Methuselah - a mini-review. Gerontology.
57:129–136. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan SR and Blackburn EH: Telomeres and
telomerase. Philos Trans R Soc Lond B Biol Sci. 359:109–121. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Lange T: How telomeres solve the
end-protection problem. Science. 326:948–952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barczak W and Rubiś B: Telomere length as
a prognostic marker in breast and lung cancer. Nowotwory.
62:376–384. 2012.
|
|
9
|
Yao YG, Ogasawara Y, Kajigaya S, Molldrem
JJ, Falcão RP, Pintão MC, McCoy JP Jr, Rizzatti EG and Young NS:
Mitochondrial DNA sequence variation in single cells from leukemia
patients. Blood. 109:756–762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: World Health Organization Classification of
Tumours of the Breast. World Health Organization Classification of
Tumours. 4:(Fourth). (Lyon). IARC Press. 2012.
|
|
11
|
Hackett JA and Greider CW: Balancing
instability: Dual roles for telomerase and telomere dysfunction in
tumorigenesis. Oncogene. 21:619–626. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gramades MM, Telli ML, Balise R and Ford
JM: Longer relative telomere length in blood from women with
sporadic and familiar breast cancer compared with healthy controls.
Cancer Epidemiol Biomarkers Prev. 19:605–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martinez-Delgado B, Yanowsky K,
Inglada-Perez L, Domingo S, Urioste M, Osorio A and Benitez J:
Genetic anticipation is associated with telomere shortening in
hereditary breast cancer. PLoS Genet. 7:e10021822011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heaphy CM, Subhawong AP, Gross AL, Konishi
Y, Kouprina N, Argani P, Visvanathan K and Meeker AK: Shorter
telomeres in luminal B, HER-2 and triple-negative breast cancer
subtypes. Mod Pathol. 24:194–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shao L, Wood CG, Zhang D, Tannir NM, Matin
S, Dinney CP and Wu X: Telomere dysfunction in peripheral
lymphocytes as a potential predisposition factor for renal cancer.
J Urol. 178:1492–1496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rubiś B, Hołysz H, Barczak W, Gryczka R,
Łaciński M, Jagielski P, Czernikiewicz A, Półrolniczak A, Wojewoda
A, Perz K, et al: Study of ABCB1 polymorphism frequency in breast
cancer patients from Poland. Pharmacol Rep. 64:1560–1566. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cawthon RM: Telomere length measurement by
a novel monochrome multiplex quantitative PCR method. Nucleic Acids
Res. 37:e212009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Callaghan NJ and Fenech M: A
quantitative PCR method for measuring absolute telomere length.
Biol Proced Online. 13:32011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kimura M, Stone RC, Hunt SC, Skurnick J,
Lu X, Cao X, Harley CB and Aviv A: Measurement of telomere length
by the Southern blot analysis of terminal restriction fragment
lengths. Nat Protoc. 5:1596–1607. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gruszecka A, Kopczyński P, Cudziło D,
Lipińska N, Romaniuk A, Barczak W, Rozwadowska N, Totoń E and Rubiś
B: Telomere shortening in Down syndrome patients - when does it
start? DNA Cell Biol. 34:412–417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Härle-Bachor C and Boukamp P: Telomerase
activity in the regenerative basal layer of the epidermis inhuman
skin and in immortal and carcinoma-derived skin keratinocytes. Proc
Natl Acad Sci USA. 93:6476–6481. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hiyama E, Tatsumoto N, Kodama T, Hiyama K,
Shay J and Yokoyama T: Telomerase activity in human intestine. Int
J Oncol. 9:453–458. 1996.PubMed/NCBI
|
|
23
|
Yasumoto S, Kunimura C, Kikuchi K, Tahara
H, Ohji H, Yamamoto H, Ide T and Utakoji T: Telomerase activity in
normal human epithelial cells. Oncogene. 13:433–439.
1996.PubMed/NCBI
|
|
24
|
Yui J, Chiu CP and Lansdorp PM: Telomerase
activity in candidate stem cells from fetal liver and adult bone
marrow. Blood. 91:3255–3262. 1998.PubMed/NCBI
|
|
25
|
Huang YK, Fan XG, Qiu F and Wang ZM:
Combined detection of mRNA expression of Alpha-fetoprotein in
peripheral blood and telomerase activity of monocytes in
hepatocellular carcinoma patients. Hepatogastroenterology. 60:1–5.
2013.PubMed/NCBI
|
|
26
|
Lu L, Zhang C, Zhu G, Irwin M, Risch H,
Menato G, Mitidieri M, Katsaros D and Yu H: Telomerase expression
and telomere length in breast cancer and their associations with
adjuvant treatment and disease outcome. Breast Cancer Res.
13:R562011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Merchant NB, Dutta SK, Girotra M, Arora M
and Meltzer SJ: Evidence for enhanced telomerase activity in
Barrett's esophagus with dysplasia and adenocarcinoma. Asian Pac J
Cancer Prev. 14:679–683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ,
Wu X and Gu J: Short telomere lengths in peripheral blood
leukocytes are associated with an increased risk of oral
premalignant lesion and oral squamous cell carcinoma. Cancer.
119:4277–4283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lan Q, Cawthon R, Gao Y, Hu W, Hosgood HD
III, Barone-Adesi F, Ji BT, Bassig B, Chow WH, Shu X, et al: Longer
telomere length in peripheral white blood cells is associated with
risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism
in a prospective cohort study among women in China. PLoS One.
8:e592302013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang
Y, Li T, Shi Y, Wei S and Nie S: Telomere length in peripheral
blood leukocytes is associated with risk of colorectal cancer in
Chinese population. PLoS One. 9:e881352014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang S, Chen Y, Qu F, He S, Huang X, Jiang
H, Jin T, Wan S and Xing J: Association between leukocyte telomere
length and glioma risk: A case-control study. Neuro Oncol.
16:505–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim S, Sandler DP, Carswell G, De Roo LA,
Parks CG, Cawthon R, Weinberg CR and Taylor JA: Telomere length in
peripheral blood and breast cancer risk in a prospective
case-cohort analysis: Results from the Sister Study. Cancer Causes
Control. 22:1061–1066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou X, Meeker AK, Makambi KH, Kosti O,
Kallakury BV, Sidawy MK, Loffredo CA and Zheng YL: Telomere length
variation in normal epithelial cells adjacent to tumor: Potential
biomarker for breast cancer local recurrence. Carcinogenesis.
33:113–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wentzensen IM, Mirabello L, Pfeiffer RM
and Savage SA: The association of telomere length and cancer: A
meta-analysis. Cancer Epidemiol Biomarkers Prev. 20:1238–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martin V, Cappuzzo F, Mazzucchelli L and
Frattini M: HER2 in solid tumors: More than 10 years under the
microscope; where are we now? Future Oncol. 10:1469–1486. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Papanikolaou V, Iliopoulos D, Dimou I,
Dubos S, Tsougos I, Theodorou K, Kitsiou-Tzeli S and Tsezou A: The
involvement of HER2 and p53 status in the regulation of telomerase
in irradiated breast cancer cells. Int J Oncol. 35:1141–1149.
2009.PubMed/NCBI
|
|
37
|
Vageli D, Ioannou MG and Koukoulis GK:
Transcriptional activation of hTERT in breast carcinomas by the
Her2-ER81-related pathway. Oncol Res. 17:413–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sugishita Y, Kammori M, Yamada O, Poon SS,
Kobayashi M, Onoda N, Yamazaki K, Fukumori T, Yoshikawa K, Onose H,
et al: Amplification of the human epidermal growth factor receptor
2 gene in differentiated thyroid cancer correlates with telomere
shortening. Int J Oncol. 42:1589–1596. 2013.PubMed/NCBI
|
|
39
|
Shen J, Terry MB, Liao Y, Gurvich I, Wang
Q, Senie RT and Santella RM: Genetic variation in telomere
maintenance genes, telomere length and breast cancer risk. PLoS
One. 7:e443082012. View Article : Google Scholar : PubMed/NCBI
|
